Jakob Dupont insider trades: Pyxis Oncology (PYXS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jakob reports to the SEC
Open-market buys and sales
29 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | PYXS | ↓ Sell | 35,000 | $3.06 | $107K | Direct | Jul 2, 2026 (2d) |
| Mar 2, 2023 | ATRA | ↓ Sell | 5,074 | $3.63 | $18K | Direct | Mar 6, 2023 (4d) |
| Nov 16, 2022 | ATRA | ↓ Sell | 4,342 | $4.49 | $19K | Direct | Nov 18, 2022 (2d) |
| Aug 16, 2022 | ATRA | ↓ Sell | 4,124 | $5.03 | $21K | Direct | Aug 18, 2022 (2d) |
| May 17, 2022 | ATRA | ↓ Sell | 3,873 | $5.32 | $21K | Direct | May 19, 2022 (2d) |
| Mar 1, 2022 | ATRA | ↓ Sell | 2,221 | $9.86 | $22K | Direct | Mar 3, 2022 (2d) |
| Feb 10, 2022 | ATRA | ↓ Sell | 5,000 | $16.00 | $80K | Direct | Feb 14, 2022 (4d) |
| Jan 3, 2022 | ATRA | ↓ Sell | 5,000 | $16.01 | $80K | Direct | Jan 5, 2022 (2d) |
| Dec 1, 2021 | ATRA | ↓ Sell | 5,000 | $17.94 | $90K | Direct | Dec 3, 2021 (2d) |
| Nov 16, 2021 | ATRA | ↓ Sell | 2,199 | $17.12 | $38K | Direct | Nov 18, 2021 (2d) |
| Nov 2, 2021 | ATRA | ↓ Sell | 5,000 | $16.41 | $82K | Direct | Nov 4, 2021 (2d) |
| Aug 17, 2021 | ATRA | ↓ Sell | 2,152 | $12.53 | $27K | Direct | Aug 19, 2021 (2d) |
| May 18, 2021 | ATRA | ↓ Sell | 5,184 | $14.55 | $75K | Direct | May 20, 2021 (2d) |
| Dec 30, 2019 | GOSS | ↓ Sell | 41,994 | $15.04 | $632K | Direct | Dec 31, 2019 (1d) |
| Jan 11, 2016 | OMED | ↓ Sell | 2,500 | $20.01 | $50K | Direct | Jan 12, 2016 (1d) |
| Jan 7, 2016 | OMED | ↓ Sell | 2,162 | $22.28 | $48K | Direct | Jan 8, 2016 (1d) |
| Dec 10, 2015 | OMED | ↓ Sell | 2,500 | $20.49 | $51K | Direct | Dec 14, 2015 (4d) |
| Nov 10, 2015 | OMED | ↓ Sell | 2,500 | $21.17 | $53K | Direct | Nov 12, 2015 (2d) |
| Oct 26, 2015 | OMED | ↓ Sell | 5,000 | $20.00 | $100K | Direct | Oct 27, 2015 (1d) |
| Aug 10, 2015 | OMED | ↓ Sell | 2,500 | $22.25 | $56K | Direct | Aug 12, 2015 (2d) |
| Jul 10, 2015 | OMED | ↓ Sell | 2,500 | $20.13 | $50K | Direct | Jul 13, 2015 (3d) |
| Jul 6, 2015 | OMED | ↓ Sell | 2,500 | $21.22 | $53K | Direct | Jul 7, 2015 (1d) |
| Apr 10, 2015 | OMED | ↓ Sell | 1,500 | $26.51 | $40K | Direct | Apr 14, 2015 (4d) |
| Mar 10, 2015 | OMED | ↓ Sell | 1,500 | $27.17 | $41K | Direct | Mar 12, 2015 (2d) |
| Feb 10, 2015 | OMED | ↓ Sell | 1,500 | $24.23 | $36K | Direct | Feb 12, 2015 (2d) |
| Jan 12, 2015 | OMED | ↓ Sell | 1,500 | $25.89 | $39K | Direct | Jan 14, 2015 (2d) |
| Jan 5, 2015 | OMED | ↓ Sell | 7,500 | $23.00 | $173K | Direct | Jan 7, 2015 (2d) |
| Jul 23, 2014 | OMED | ↓ Sell | 1,500 | $23.00 | $35K | Direct | Jul 25, 2014 (2d) |
| Jun 26, 2014 | OMED | ↓ Sell | 1,500 | $23.00 | $35K | Direct | Jun 30, 2014 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Jakob Dupont's insider trades
Jakob Dupont is an insider at Pyxis Oncology (PYXS). Since Jun 26, 2014, Jakob has reported no open-market purchases and 29 sales worth $2.2M on SEC Form 4. In the last 12 months: 1 sale ($107K).
Their filings also include grants and awards (23 filings), option exercises (20 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PYXS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.